検索結果一覧

一般口演 / Oral Session

一般口演 25 (Oral Session 25) :CML:基礎 2
 
日程
2013年10月11日(金)
時間
14:25 - 15:25
会場
第7会場 / Room No.7 (ロイトン札幌 2F リージェント)
座長・司会
中前 博久 (Hirohisa Nakamae):1
1:大阪市立大学大学院医学研究科 血液腫瘍制御学

前へ戻る


Dasatinib specifically increases CD57+CD14- cells, associated with decreased M-BCR-ABL mRNA in CML

演題番号 : OS-1-125

熊谷 隆志 (Takashi Kumagai):1、松木 絵里 (Eri Matsuki):2、猪口 孝一 (Koichi Inokuchi):3、大橋 一輝 (Kazuteru Ohashi):4、品川 篤司 (Atsushi Shinagawa):5、竹内 仁 (Jin Takeuchi):6、吉田 近思 (Chikashi Yoshida):7、岡本 真一郎 (Shinichiro Okamoto):2、脇田 久 (Hisashi Wakita):8、香西 康司 (Yasuji Kouzai):9、白杉 由香里 (Yukari Shirasugi):10、藤沢 信 (Shin Fujisawa):11、岩瀬 理 (Osamu Iwase):12、矢野 真吾 (Shingo Yano):13、西脇 嘉一 (Kaichi Nishiwaki):14、大庭 幸治 (Koji Oba):15、坂本 純一 (Junichi Sakamoto):16、坂巻 壽 (Hisashi Sakamaki):4

1:Department of Hematology, Ohme Municipal General Hospital, Tokyo, Japan、2:Division of Hematology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan、3:Division of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan、4:Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan、5:Department of Internal Medicine, Hitachi General Hospital, Hitachi, Ibaraki, Japan、6:Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan、7:Department of Hematology, National Hospital Organization Mito Medical Center, Ibaraki, Japan、8:Division of Hematology and Oncology, Japanese Red Cross Society, Narita Red Cross Hospital, Narita, Japan、9:Department of Hematology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan、10:Division of Hematology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan、11:Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan、12:Division of Hematology, Hachioji Medical Center, Tokyo Medical University, Tokyo, Japan、13:Division of Clinical Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan、14:Division of Oncology and Hematology, Department of Internal Medicine, Jikei University Kashiwa Hospital, Kashiwa, Japan、15:Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan、16:Tokai Central Hospital, Kakamigahara, Japan

Dasatinib specifically increases CD57+CD14- cells, associated with decreased  M-BCR-ABL mRNA in CML

Long-term up-regulation of effector NK cells in CML after stopping imatinib

演題番号 : OS-1-126

片桐 誠一朗 (Seiichiro Katagiri):1、溝口 出 (Izuru Mizoguchi):2、善本 隆之 (Takayuki Yoshimoto):2、大屋敷 純子 (Junko H. Ohyashiki):3、田内 哲三 (Tetsuzo Tauchi):1、猪口 孝一 (Koichi Inokuchi):4、大屋敷 一馬 (Kazuma Ohyashiki):1

1:Department of Hematology, Tokyo Medical University、2:Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University、3:Department of Molecular Oncology, Institute of Medical Science, Tokyo Medical University、4:Department of Hematology, Nippon Medical School

Long-term up-regulation of effector NK cells in CML after stopping imatinib

Dasatinib-induced LGL possibly correlates with TCRγ clonality and lower Treg ratio at diagnosis

演題番号 : OS-1-127

志村 勇司 (Yuji Shimura):1、堀池 重夫 (Shigeo Horiike):1、堤 康彦 (Yasuhiko Tsutsumi):2、初瀬 真弓 (Mayumi Hatsuse):3、岡野 晃 (Akira Okano):3、淵田 真一 (Shin-Ichi Fuchida):3、松本 洋典 (Yosuke Matsumoto):1、黒田 純也 (Junya Kuroda):1、高橋 良一 (Ryoichi Takahashi):4、志村 和穂 (Kazuho Shimura):5、兼子 裕人 (Hiroto Kaneko):2、西垣 光 (Hikari Nishigaki):6、魚嶋 伸彦 (Nobuhiko Uoshima):7、小林 裕 (Yutaka Kobayashi):8、島崎 千尋 (Chihiro Shimazaki):3、谷脇 雅史 (Masafumi Taniwaki):1

1:Dept. Hematology and Oncology, Kyoto Pref. Univ. of Medicine, Japan、2:Dept. Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Japan、3:Dept. Hematology, Social Insurance Kyoto Hospital, Japan、4:Dept. Hematology, Omihachiman Community Medical Center, Shiga, Japan、5:Dept. Hematology, Aiseikai-Yamashina Hospital, Kyoto, Japan、6:Dept. Hematology, Fukuchiyama City Hospital, Japan、7:Dept. Hematology, Matsushita Memorial Hospital, Osaka, Japan、8:Dept. Hematology, Japanese Red Cross Kyoto Daiini Hospital, Japan

Dasatinib-induced LGL possibly correlates with TCRγ clonality and lower Treg ratio at diagnosis

Ponatinib induced thrombocytopenia might be due to the inhibition of proplatelet formation

演題番号 : OS-1-128

村井 一範 (Kazunori Murai):1、古和田 周吾 (Shugo Kowata):1、菅原 教史 (Norifumi Sugawara):1、藤澤 佑香 (Yuka Fujisawa):1、佐々木 了政 (Ryousei Sasaki):1、藤島 行輝 (Yukiteru Fujishima):1、峯 貴浩 (Takahiro Mine):1、小宅 達郎 (Tatsuo Oyake):1、伊藤 薫樹 (Shigeki Ito):1、石田 陽治 (Yoji Ishida):1

1:Hematology/Oncology, Iwate Medical Univ., Japan

Ponatinib induced thrombocytopenia might be due to the inhibition of  proplatelet formation

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Dasatinib in CML-CP

演題番号 : OS-1-129

石田 陽治 (Yoji Ishida):1,3、村井 一範 (Kazunori Murai):1,3、山口 公平 (Kohei Yamaguchi):3、宮城島 拓人 (Takuto Miyagishima):3、進藤 基博 (Motohiro Shindo):3、小川 一英 (Kazuei Ogawa):3、永嶋 貴博 (Takahiro Nagashima):3、佐藤 伸二 (Shinji Sato):3、渡部 玲子 (Reiko Watanabe):3、山本 聡 (Satoshi Yamamoto):3、廣瀬 貴之 (Takayuki Hirose):3、齊藤 宗一 (Sohichi Saitoh):3、米積 昌克 (Masakatsu Yonezumi):3、近藤 健 (Takeshi Kondo):3、加藤 裕一 (Yuichi Kato):3、望月 伸夫 (Nobuo Mochizuki):2、大野 恵子 (Keiko Ohno):2、岸野 官吏 (Satoshi Kishino):2、伊藤 薫樹 (Shigeki Ito):1,3、久保 恒明 (Koumei Kubo):3

1:Hematology/ Oncology, Iwate Medical University School of Medicine、2:Meiji Pharmaceutical University、3:Inter-Michinoku Dasatinib Study Group

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Dasatinib in CML-CP